Cargando…

Moyamoya disease and syndromes: from genetics to clinical management

Moyamoya angiopathy is characterized by a progressive stenosis of the terminal portion of the internal carotid arteries and the development of a network of abnormal collateral vessels. This chronic cerebral angiopathy is observed in children and adults. It mainly leads to brain ischemic events in ch...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guey, Stéphanie, Tournier-Lasserve, Elisabeth, Hervé, Dominique, Kossorotoff, Manoelle
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4337618/ https://www.ncbi.nlm.nih.gov/pubmed/25733922 http://dx.doi.org/10.2147/TACG.S42772

Ejemplares similares

Predictors of clinical or cerebral lesion progression in adult moyamoya angiopathy
por: Hervé, Dominique, et al.
Publicado: (2019)

Biallelic variants in NOS3 and GUCY1A3, the two major genes of the nitric oxide pathway, cause moyamoya cerebral angiopathy
por: Guey, Stéphanie, et al.
Publicado: (2023)

The Genetic Basis of Moyamoya Disease
por: Mertens, R., et al.
Publicado: (2021)

Phenotypic variability in 446 CADASIL patients: Impact of NOTCH3 gene mutation location in addition to the effects of age, sex and vascular risk factors
por: Dupé, Charlotte, et al.
Publicado: (2022)

Clinical Management of Moyamoya Patients
por: Canavero, Isabella, et al.
Publicado: (2021)

Moyamoya Syndrome: A Window of Moyamoya Disease
por: Phi, Ji Hoon, et al.
Publicado: (2015)

Elderly CADASIL patients with intact neurological status
por: Zhang, Ruiting, et al.
Publicado: (2022)

Imaging of Moyamoya Disease and Moyamoya Syndrome: Current Status
por: Li, Jincheng, et al.
Publicado: (2019)

Moyamoya disease and syndrome: a review
por: Demartini Jr., Zeferino, et al.
Publicado: (2022)

Influence of Inflammatory Disease on the Pathophysiology of Moyamoya Disease and Quasi-moyamoya Disease
por: MIKAMI, Takeshi, et al.
Publicado: (2019)

Limits and pitfalls of indirect revascularization in moyamoya disease and syndrome
por: Fiaschi, Pietro, et al.
Publicado: (2020)

Vascular Remodeling in Moyamoya Angiopathy: From Peripheral Blood Mononuclear Cells to Endothelial Cells
por: Tinelli, Francesca, et al.
Publicado: (2020)

Phakomatoses and cutaneous manifestations associated with moyamoya disease and syndrome
por: Tomaszewska, Maja, et al.
Publicado: (2021)

Moyamoya Disease: Epidemiology, Clinical Features, and Diagnosis
por: Kim, Jong S.
Publicado: (2016)

Difference in Cerebral Circulation Time between Subtypes of Moyamoya Disease and Moyamoya Syndrome
por: Kang, Kaijiang, et al.
Publicado: (2017)

Genetic and Proteomic Contributions to the Pathophysiology of Moyamoya Angiopathy and Related Vascular Diseases
por: Dorschel, Kirsten B, et al.
Publicado: (2021)

Moyamoya Disease and Syndrome in Caucasian Patients
por: Neves, Nuno, et al.
Publicado: (2023)

Characteristics of Moyamoya Syndrome in Sickle-Cell Disease by Magnetic Resonance Angiography: An Adult-Cohort Study
por: Kauv, Paul, et al.
Publicado: (2019)

2021 Japanese Guidelines for the Management of Moyamoya Disease: Guidelines from the Research Committee on Moyamoya Disease and Japan Stroke Society
por: FUJIMURA, Miki, et al.
Publicado: (2022)

Moyamoya disease: Diagnostic imaging
por: Tarasów, Eugeniusz, et al.
Publicado: (2011)

Moyamoya Disease: Treatment and Outcomes
por: Kim, Tackeun, et al.
Publicado: (2016)

The Pathophysiology of Moyamoya Disease: An Update
por: Bang, Oh Young, et al.
Publicado: (2016)

Genetics and Biomarkers of Moyamoya Disease: Significance of RNF213 as a Susceptibility Gene
por: Fujimura, Miki, et al.
Publicado: (2014)

Research Progress of Moyamoya Disease in Children
por: Piao, Jianmin, et al.
Publicado: (2015)

Pathological Circulating Factors in Moyamoya Disease
por: Fang, Yao-Ching, et al.
Publicado: (2021)

Clinical and Immunopathological Features of Moyamoya Disease
por: Lin, Runhua, et al.
Publicado: (2012)

Extension of the Clinicoradiologic Spectrum of Newly Described End-Truncating LAMB1 Variations
por: Morel, Hélène, et al.
Publicado: (2023)

Differences in Clinical Features among Different Onset Patterns in Moyamoya Disease
por: Hirano, Yudai, et al.
Publicado: (2021)

Main features of COL4A1-COL4A2 related cerebral microangiopathies
por: Guey, Stéphanie, et al.
Publicado: (2022)

A case of reversible pulmonary arterial hypertension associated with incontinentia pigmenti
por: Atallah, Veronique, et al.
Publicado: (2018)

Treatment Strategies for Aneurysms Associated with Moyamoya Disease
por: Zhang, Lei, et al.
Publicado: (2015)

Progress on Complications of Direct Bypass for Moyamoya Disease
por: Yu, Jinlu, et al.
Publicado: (2016)

Down Syndrome with Moyamoya Disease: A Case Series
por: Kumar, Pawan, et al.
Publicado: (2018)

Increased Autoimmunity in Individuals With Down Syndrome and Moyamoya Disease
por: Santoro, Jonathan D., et al.
Publicado: (2021)

Indirect revascularization vs. non-surgical treatment for Moyamoya disease and Moyamoya syndrome: A comparative effectiveness study
por: Wang, Yixuan, et al.
Publicado: (2022)

Burden of dilated perivascular spaces in patients with moyamoya disease and moyamoya syndrome is related to middle cerebral artery stenosis
por: Han, Guangsong, et al.
Publicado: (2023)

Pediatric Moyamoya disease
por: Nagiub, Mohamed, et al.
Publicado: (2013)

Editorial: Moyamoya disease
por: Gu, Yuxiang
Publicado: (2022)

West Syndrome Is an Exceptional Presentation of Pyridoxine- and Pyridoxal Phosphate-Dependent Epilepsy: Data From a French Cohort and Review of the Literature
por: Gibaud, Marc, et al.
Publicado: (2021)

Moyamoya Syndrome after Radiation Therapy: a Clinical Report
por: Almeida, Paulo, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_bslb1pcgt2n5mit28rciqulu5b